Compound information
- Natural Products
- ZC781978
- Molecular Formula
- C9H9BrN2O3
- Molecular Weight
- 271.979654248 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-bromo-N-(4-nitrophenyl)propanamide
- InChI
- InChI=1S/C9H9BrN2O3/c1-6(10)9(13)11-7-2-4-8(5-3-7)12(14)15/h2-6H,1H3,(H,11,13)/t6-/m0/s1
- InChI Key
- MVMJCTRTLGXJRA-LURJTMIESA-N
- SMILES
- C[C@H](Br)C(=O)Nc1ccc([N+](=O)[O-])cc1
- Source
- ZINC000005354027
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 15 | Ring Count | 1 |
| Heteroatom Count | 6 | Rotatable Bond Count | 3 |
| Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 72.24 Å2 | LogP | 2.451 |
| LogS | -3.838 | LogD | 2.409 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.033 | Pgp substrate | 0.002 |
| HIA | 0.962 | F20 % | 0.993 |
| F30 % | 0.971 | Caco-2 | -4.776 |
| MDCK | -4.71 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.145 | PPB | 41.836 |
| VD | 0.703 | Fu | 0.477 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.965 | CYP1A2 substrate | 0.707 |
| CYP2A6 substrate | 0.872 | CYP2B6 substrate | 0.546 |
| CYP2C19 inhibitor | 0.313 | CYP2C19 substrate | 0.937 |
| CYP2C8 substrate | 0.793 | CYP2C9 inhibitor | 0.562 |
| CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.015 |
| CYP2D6 substrate | 0.793 | CYP2E1 substrate | 0.751 |
| CYP3A4 inhibitor | 0.042 | CYP3A4 substrate | 0.902 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.409 | CL | 7.898 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.021 | Hepatotoxicity | 0.994 |
| Mutagenicity | 0.827 | Rat Oral Acute Toxicity | 0.162 |
| FDAMDD | 0.037 | Skin Sensitization | 0.996 |
| Carcinogenicity | 0.895 | Eye Corrosion | 0.998 |
| Eye Irritation | 0.974 | Respiratory Toxicity | 0.973 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.536 | IGC50 | 4.579 |
| LC50FM | 4.702 | LC50DM | 4.667 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.277 | NR-AR-LBD | 0.332 |
| NR-AhR | 0.89 | NR-Aromatase | 0.181 |
| NR-ER | 0.484 | NR-ER-LBD | 0.508 |
| NR-PPAR-gamma | 0.581 | SR-ARE | 0.536 |
| SR-ATAD5 | 0.657 | SR-HSE | 0.185 |
| SR-MMP | 0.458 | SR-p53 | 0.694 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.